Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis

Introduction: We aimed to investigate whether a lower starting dose of roxadustat (∼1–1.4 mg/kg) converted from erythropoiesis-stimulating agent (ESA) could achieve a comparable hemoglobin (Hb) target (≥100 and ≤120 g/l) compared with the standard weight-based dose (∼1.5–2 mg/kg) at week 12 through...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhikai Yang, Tiantian Ma, Xiao Xu, Gang Fu, Jing Zhao, Ying Xu, Bin Yang, Di Song, Sainan Zhu, Jicheng Lv, Jie Dong
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2022-03-01
Serie:	Kidney International Reports
Soggetti:	hypoxia-inducible factor prolyl hydroxylase inhibitor peritoneal dialysis renal anemia roxadustat
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2468024921016156
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!